Custom Perfusion System (CUSTOM PACK BB7W03R8 CCSM NEON). The Affinity Pixie Cardiotomy/Venous Re...

FDA Device Recall #Z-1199-2021 — Class I — February 4, 2021

Recall Summary

Recall Number Z-1199-2021
Classification Class I — Serious risk
Date Initiated February 4, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Medtronic Perfusion Systems
Location Brooklyn Park, MN
Product Type Devices
Quantity 7 units

Product Description

Custom Perfusion System (CUSTOM PACK BB7W03R8 CCSM NEON). The Affinity Pixie Cardiotomy/Venous Reservoir (CVR) with Balance Biosurface is a single-use device designed to collect and store blood during extracorporeal circulation. Cardiotomy blood is collected, filtered, and defoamed before mixing with the venous blood, which is filtered. The primary blood-contacting surfaces of the CVR are coated with Balance Biosurface to reduce platelet activation and adhesion and preserve platelet function. (Generic Name: Cardiopulmonary bypass oxygenator).

Reason for Recall

Products being recalled due to potentially elevated level of bacterial endotoxin. Patients exposed to elevated levels of bacterial endotoxins may develop an acute inflammatory response.

Distribution Pattern

Worldwide distribution: US nationwide, Afghanistan, Argentina, Chile, China, Colombia, Egypt, Germany, Iraq, Italy, Japan, Korea, Kyrgyzstan, Latvia, Nicaragua, Paraguay, Poland, Qatar, Romania, Tanzania, United Arab Emirates, United Kingdom, Uzbekistan, and Viet Nam

Lot / Code Information

Description: CUSTOM PACK BB7W03R8 CCSM NEON. Model Number: BB7W03R8. GTIN: 00643169990562. Lot Number: 220911945.

Other Recalls from Medtronic Perfusion Systems

Recall # Classification Product Date
Z-1473-2026 Class II Octopus Nuvo Tissue Stabilizer, disposable tiss... Jan 13, 2026
Z-0539-2026 Class II Medtronic HR-ACT (High Range Activated Clotting... Oct 20, 2025
Z-0509-2026 Class II MC3 VitalFlow Console, REF 58100; Blood pump of... Oct 3, 2025
Z-0487-2026 Class II Affinity NT Oxygenator, Oxygenator with Balance... Sep 12, 2025
Z-2481-2025 Class I DLP Left Heart Vent Catheter Malleable body and... Aug 6, 2025

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.